Artículo

Almejún, M.B.; Borge, M.; Colado, A.; Elías, E.E.; Podaza, E.; Risnik, D.; De Brasi, C.D.; Stanganelli, C.; Slavutsky, I.; Cabrejo, M.; Fernández-Grecco, H.; Bezares, R.F.; Cranco, S.; Burgos, R.Á.; Sánchez-Ávalos, J.C.; Oppezzo, P.; Giordano, M.; Gamberale, R. "Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells" (2017) Haematologica. 102(7):e257-e260
Estamos trabajando para incorporar este artículo al repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Registro:

Documento: Artículo
Título:Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells
Autor:Almejún, M.B.; Borge, M.; Colado, A.; Elías, E.E.; Podaza, E.; Risnik, D.; De Brasi, C.D.; Stanganelli, C.; Slavutsky, I.; Cabrejo, M.; Fernández-Grecco, H.; Bezares, R.F.; Cranco, S.; Burgos, R.Á.; Sánchez-Ávalos, J.C.; Oppezzo, P.; Giordano, M.; Gamberale, R.
Filiación:Laboratorio de Inmunología Oncológica, Instituto de Medicina Experimental (IMEX)-CONICET-Academia Nacional de Medicina (ANM), Buenos Aires, Argentina
Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina
Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Argentina
Laboratorio de Genética Molecular de la Hemofilia, IMEX-CONICET-ANM, Buenos Aires, Argentina
División Patología Molecular, Instituto de Investigaciones Hematológicas “Mariano R. Castex”, Academia Nacional de Medicina, Buenos Aires, Argentina
Laboratorio de Genética de Neoplasias Linfoides, IMEX-CONICET-ANM, Buenos Aires, Argentina
Sanatorio Municipal Dr. Julio Méndez, Buenos Aires, Argentina
Hospital General de Agudos Dr. Teodoro Álvarez, Buenos Aires, Argentina
Instituto Alexander Fleming, Buenos Aires, Argentina
Research Laboratory on Chronic Lymphocytic Leukemia, Institut Pasteur de Montevideo, Montevideo, Uruguay
Palabras clave:B lymphocyte receptor; beta 2 microglobulin; beta actin; carboxyfluorescein diacetate succinimidyl ester; CD38 antigen; CD40 ligand; CD49 antigen; CD69 antigen; epigallocatechin gallate; immunoglobulin G; immunoglobulin M; immunoglobulin M antibody; lactate dehydrogenase; messenger RNA; sphingosine kinase 1; unclassified drug; biological marker; phosphotransferase; sphingosine kinase; B lymphocyte; cell activation; cell adhesion; cell death; cell migration; cell proliferation; cell survival; chronic lymphatic leukemia; clinical article; clinical outcome; controlled study; densitometry; disease association; disease course; down regulation; female; human; Letter; male; peripheral blood mononuclear cell; prognosis; protein expression; real time polymerase chain reaction; thrombocyte; upregulation; Western blotting; cell proliferation; cell survival; chronic lymphatic leukemia; disease exacerbation; genetics; immunophenotyping; metabolism; pathology; signal transduction; Biomarkers; Cell Proliferation; Cell Survival; Disease Progression; Female; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Phosphotransferases (Alcohol Group Acceptor); Signal Transduction
Año:2017
Volumen:102
Número:7
Página de inicio:e257
Página de fin:e260
DOI: http://dx.doi.org/10.3324/haematol.2017.167353
Título revista:Haematologica
Título revista abreviado:Haematologica
ISSN:03906078
CODEN:HAEMA
CAS:beta 2 microglobulin, 9066-69-7; CD40 ligand, 226713-27-5; epigallocatechin gallate, 989-51-5; immunoglobulin G, 97794-27-9; immunoglobulin M, 9007-85-6; lactate dehydrogenase, 9001-60-9; phosphotransferase, 9031-09-8, 9031-44-1; sphingosine kinase, 50864-48-7; Biomarkers; Phosphotransferases (Alcohol Group Acceptor); sphingosine kinase
Registro:http://digital.bl.fcen.uba.ar/collection/paper/document/paper_03906078_v102_n7_pe257_Almejun

Referencias:

  • Spiegel, S., Milstien, S., The outs and the ins of sphingosine-1-phosphate in immunity (2011) Nat Rev Immunol, 11 (6), pp. 403-415
  • Newton, J., Lima, S., Maceyka, M., Spiegel, S., Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy (2015) Exp Cell Res, 333 (2), pp. 195-200
  • Evangelisti, C., Evangelisti, C., Buontempo, F., Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies (2016) Leukemia, 30 (11), pp. 2142-2151
  • Rodriguez, Y.I., Campos, L.E., Castro, M.G., Aladhami, A., Oskeritzian, C.A., Alvarez, S.E., Sphingosine-1 phosphate: A new modulator of immune plasticity in the tumor microenvironment (2016) Front Oncol, 6, p. 218
  • Burger, J.A., Nurture versus nature: The microenvironment in chronic lymphocytic leukemia (2011) Hematology am Soc Hematol Educ Program. 2012, pp. 96-103
  • Borge, M., Remes Lenicov, F., Nannini, P.R., The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406 (2014) J Immunol, 193 (6), pp. 3165-3174
  • Palacios, F., Moreno, P., Morande, P., High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: Link with an activated microenvironment in CLL disease (2010) Blood, 115 (22), pp. 4488-4496
  • French, K.J., Upson, J.J., Keller, S.N., Zhuang, Y., Yun, J.K., Smith, C.D., Antitumor activity of sphingosine kinase inhibitors (2006) J Pharmacol Exp Ther, 318 (2), pp. 596-603
  • Beider, K., Rosenberg, E., Bitner, H., The sphingosine-1-phosphate modulator FTY720 targets multiple myeloma via the CXCR4/CXCL12 pathway (2016) Clin Cancer Res, , Oct 3. [Epub ahead of print]
  • Yang, L., Weng, W., Sun, Z.X., Fu, X.J., Ma, J., Zhuang, W.F., SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo (2015) Biochem Biophys Res Commun, 460 (4), pp. 903-908
  • Leblanc, F.R., Liu, X., Hengst, J., Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia (2015) Cancer Biol Ther, 16 (12), pp. 1830-1840
  • Tsukamoto, S., Kumazoe, M., Huang, Y., SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells (2016) Br J Haematol, , May 25. [Epub ahead of print]
  • Dielschneider, R.F., Eisenstat, H., Mi, S., Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism (2016) Leukemia, 30 (6), pp. 1290-1300
  • Li, P.H., Wu, J.X., Zheng, J.N., Pei, D.S., A sphingosine kinase-1 inhibitor, SKI-II, induces growth inhibition and apoptosis in human gastric cancer cells (2014) Asian Pac J Cancer Prev, 15 (23), pp. 10381-11038

Citas:

---------- APA ----------
Almejún, M.B., Borge, M., Colado, A., Elías, E.E., Podaza, E., Risnik, D., De Brasi, C.D.,..., Gamberale, R. (2017) . Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells. Haematologica, 102(7), e257-e260.
http://dx.doi.org/10.3324/haematol.2017.167353
---------- CHICAGO ----------
Almejún, M.B., Borge, M., Colado, A., Elías, E.E., Podaza, E., Risnik, D., et al. "Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells" . Haematologica 102, no. 7 (2017) : e257-e260.
http://dx.doi.org/10.3324/haematol.2017.167353
---------- MLA ----------
Almejún, M.B., Borge, M., Colado, A., Elías, E.E., Podaza, E., Risnik, D., et al. "Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells" . Haematologica, vol. 102, no. 7, 2017, pp. e257-e260.
http://dx.doi.org/10.3324/haematol.2017.167353
---------- VANCOUVER ----------
Almejún, M.B., Borge, M., Colado, A., Elías, E.E., Podaza, E., Risnik, D., et al. Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells. Haematologica. 2017;102(7):e257-e260.
http://dx.doi.org/10.3324/haematol.2017.167353